Skip to content

Study Details

A Study of Children and Adults with Tuberous Sclerosis Complex-related Epilepsy

(IRB#: IRB_00150885)

Ganaxolone is a study drug to help children and adults with Tuberous Sclerosis Complex-related (TSC) Epilepsy. Research is needed to learn how safe and effective the study drug is at reducing the number of seizures a child or adult has when added to the current epilepsy treatment and drug(s).


  • All genders
  • All Ages
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: All Ages

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 1 to 65 years old
  • Diagnosis of TSC
  • On a stable dose of anti-epileptic medication
  • History of at least 8 seizures per month in the past 2 months
  • Unable to control seizures with 2 or more anti-epileptic medications

Exclusion Criteria

  • Pregnant or breastfeeding
  • Taking felbamate for less than 1 year
  • Taking CBD preparations other than Epidiolex

Will I be paid for my time?


For more information contact:

Carly Straley


IRB#: IRB_00150885

PI: Matthew Sweney


Approval Date: 2023-01-19 07:00:00

Study Categories: Brain Health Studies

Specialties: Neurology

Last Updated: 6/8/23